Vela Diagnostics receives BARDA funding to develop COVID-19 tests
PRIVATEApr 20, 2020
Amount Raised
$225,000
Round Type
Pre-Seed
Fairfield
Description
Vela Diagnostics has been awarded a $225,000 contract by the Biomedical Advanced Research and Development Authority (BARDA) part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, to develop manual and automated tests to detect SARS-CoV-2, the virus that causes COVID-19.
Who to call at Vela Diagnostics, and when
A new round usually means Vela Diagnostics is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Vela Diagnostics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Vela Diagnostics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Vela Diagnostics. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Vela Diagnostics
Location
Fairfield, Texas, United States
About
Vela Diagnostics is a leading provider of an automated IVD Next–Generation Sequencing (NGS) workflow in the global diagnostics market. VELA's real-time PCR and NGS applications are available on an integrated Sentosa™ platform; this provides a unique ability to leverage one system for two workflows, while carrying out tests for various targets in order to answer current clinical and research questions, as well as to drive laboratory operational efficiency.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Vela Diagnostics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Fairfield